by classicusdigital | Dec 2, 2022 | Clinical Trials
Mentors: Dr. Carolina Camargo de Oliveira and Dr. Edvaldo Da Silva Trindade https://acervodigital.ufpr.br/handle/1884/44991 Melanoma comprises the leading cause of death from skin cancer, especially because it is highly refractory to existing therapies. Tumor cells...
by classicusdigital | Dec 2, 2022 | Clinical Trials
Our research team at Federal University have studied in vitro and in vivo cancer cells treated with homeopathy in the last 20 years. After using different products and analyzing the different results carefully, we arrived at two complexes produced with homeopathic...
by classicusdigital | Dec 2, 2022 | Clinical Trials
JENIFER PENDIUK GONÇALVES1*, FRANCINE BITTENCOURT POTRICH1*, MARIA LUIZA FERREIRA DOS SANTOS1 , VIVIANA STEPHANIE COSTA GAGOSIAN1 , GUSTAVO RODRIGUES ROSSI1 , THIAGO JACOMASSO1 , ALINE MENDES2 , HELENA BONCIANI NADER2 , SHEILA MARIA BROCHADO WINNISCHOFER3 , EDVALDO S....
by classicusdigital | Dec 2, 2022 | Clinical Trials
It is an attractive target for new chemopreventive and chemotherapeutic approaches. The aim of this work is to develop highly diluted natural complexes with anti-cancer properties without side effects. One of them is a complex matrix from Chelidonium and associations,...
by classicusdigital | Dec 2, 2022 | Clinical Trials
Stimulation of lymphocyte anti-melanoma activity by co-cultured macrophages activated by complex homeopathic medication guimaraes 2009 BMC...
by classicusdigital | Dec 2, 2022 | Clinical Trials
The leukocytes interact with tumor cells to influence the development of tumors. In general, monocytes/macrophages can be polarized to M1 or M2 macrophages, that is, macrophages can differentiate into a classically or alternatively activated phenotype. Classically...
